3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
UNKNOWN
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Endocrine
1
Conditions
Breast Neoplasms
26
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
9
Lung Neoplasms
6
Uterine Cervical Neoplasms
5
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neoplasms
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Neurofibrosarcoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Cholangiocarcinoma
2
Interventions
Temozolomide
162
Radiosurgery
115
Radiotherapy
100
Bevacizumab
96
Magnetic Resonance Spectroscopy
65
Carboplatin
48
Etoposide
34
pembrolizumab
33
Surgical Procedures, Operative
33
Irinotecan
33
Nivolumab
32
Cyclophosphamide
32
Erlotinib Hydrochloride
31
Radiation
30
Carmustine
28
Lomustine
25
Cisplatin
25
Trastuzumab
23
Ipilimumab
23
Filgrastim
23
Vincristine
20
Mental Status and Dementia Tests
20
Aminolevulinic Acid
19
Topotecan
18
Pemetrexed
18
Capecitabine
18
Specimen Handling
17
Sorafenib
15
Radiotherapy, Intensity-Modulated
15
Imatinib Mesylate
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Brain Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT03778541
2019-07-23
HFSRT With Concurrent TMZ for Large BMs
ChineseAMS
Phase 3
Unknown
224 enrolled